On the Eve of BIO 2026, Chinese Innovative Assets Trigger a New Wave of Global Collaborations

On the eve of the highly anticipated BIO International Convention 2026, the BIOSeedin Summer Innovation Partnering Summit ...
BioWorld

Gensci-134: a long-acting growth hormone receptor agonist fusion protein

Gensci-134 (Genescience Pharmaceuticals Co. Ltd.) is a growth hormone receptor (GHR) agonist fusion protein that mimics the biological activity of growth hormone (GH), does not contain GH sequence and ...
AOL

On the Eve of BIO 2026, Chinese Innovative Assets Trigger a New Wave of Global Collaborations

SAN DIEGO , July 8, 2026 /PRNewswire/ -- On the eve of the highly anticipated BIO International Convention 2026, the BIOSeedin Summer Innovation Partnering Summit successfully took place in San Diego.
BioWorld

Changchun Genescience Pharmaceuticals discloses new VAV1 degradation inducers

Changchun Genescience Pharmaceuticals Co. Ltd. has synthesized new molecular glue degraders comprising E3 ubiquitin-protein ligase-binding agents acting as proto-oncogene Vav (VAV1) degradation ...
RAPS

RAPS Awards Program

Honoring excellence. Celebrating leadership. Advancing the profession. The RAPS Awards Program recognizes and celebrates regulatory professionals who demonstrate exceptional commitment, innovation, ...
GitHub

forbes_2022_billionaires.csv

Customer stories Events & webinars Ebooks & reports Business insights GitHub Skills ...